Delphine O’Rourke, Esq. is trusted counsel to health industry leaders. She partners with healthcare organizations, boards of directors and executive management teams to solve their greatest regulatory challenges, manage crisis situations and recover from emergencies and disasters.
Delphine is currently advising companies, health care entities and hospital associations across the country in preparing, responding and recovering from the COVID-19 epidemic. She has spoken on legal issues relating to COVID-19 with over 850 health care leaders, authored the first overview and toolkit for healthcare preparedness, been featured on podcasts regarding break regulations, and interviewed by national media outlets.
Delphine’s regulatory practice also focuses on:
• Federal and state laws and regulations governing access, delivery and payment for medical care in the United States including EMTALA, the federal Anti-Kickback Statute, Stark Law and state fraud and abuse provisions, patient care issues, medical staff matters, licensure, accreditation and tax exemption.
• Strategic affiliations & complex provider transactions and advising clients about potential arrangements with other healthcare providers, supply chain relationships, as well as assisting clients with internal investigations, acquisition due diligences and corporate compliance matters.
• Health care innovation with a particular emphasis on analyzing the laws and regulations applicable to mobile health applications, private equity investment in health care and consumer-driven care platforms.
Clients and industry experts also rely on Delphine to engage with their key stakeholders on the topics including the impact of new legislation on the health economy, transformative changes to access, delivery and investment in health care. Her insight and commentary have been featured by Modern Healthcare, Bloomberg Law, Law360 and other leading legal and industry publications